SRXN1 and hepatocellular carcinoma: Meanwhile, our study indicated that SRXN1 might play a pivotal role in the tumorigenesis and progression of HCC and could predict outcomes of HCC patients by being integrated to the current nomogram model, which might guide the clinical therapies.